Published in Curr Protoc Protein Sci on August 01, 2010
Probing protein quinary interactions by in-cell nuclear magnetic resonance spectroscopy. Biochemistry (2015) 0.79
A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature (2000) 47.15
Global landscape of protein complexes in the yeast Saccharomyces cerevisiae. Nature (2006) 24.29
BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res (2003) 18.75
Gradient-tailored excitation for single-quantum NMR spectroscopy of aqueous solutions. J Biomol NMR (1992) 17.71
The fluorescent toolbox for assessing protein location and function. Science (2006) 14.02
Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science (1991) 10.16
The protein-protein interaction map of Helicobacter pylori. Nature (2001) 8.71
Discovering high-affinity ligands for proteins: SAR by NMR. Science (1996) 7.10
Relating whole-genome expression data with protein-protein interactions. Genome Res (2002) 5.78
Reading protein modifications with interaction domains. Nat Rev Mol Cell Biol (2006) 4.55
Distinct monoubiquitin signals in receptor endocytosis. Trends Biochem Sci (2003) 3.37
Mapping protein-protein interactions in solution by NMR spectroscopy. Biochemistry (2002) 3.31
Role of protein ubiquitylation in regulating endocytosis of receptor tyrosine kinases. Oncogene (2004) 3.27
From words to literature in structural proteomics. Nature (2003) 2.80
The use of 2H, 13C, 15N multidimensional NMR to study the structure and dynamics of proteins. Annu Rev Biophys Biomol Struct (1998) 2.76
Mapping structural interactions using in-cell NMR spectroscopy (STINT-NMR). Nat Methods (2006) 2.15
High-resolution multi-dimensional NMR spectroscopy of proteins in human cells. Nature (2009) 2.06
Perspectives on NMR in drug discovery: a technique comes of age. Nat Rev Drug Discov (2008) 1.95
Nuclear magnetic resonance spectroscopy of high-molecular-weight proteins. Annu Rev Biochem (2004) 1.84
Molecular machines for protein degradation. Chembiochem (2005) 1.81
Computational identification of transcription factor binding sites via a transcription-factor-centric clustering (TFCC) algorithm. J Mol Biol (2002) 1.73
Protein structure determination in living cells by in-cell NMR spectroscopy. Nature (2009) 1.71
Quantitative NMR analysis of the protein G B1 domain in Xenopus laevis egg extracts and intact oocytes. Proc Natl Acad Sci U S A (2006) 1.70
The interface of receptor trafficking and signalling. J Cell Sci (2001) 1.56
Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem (2008) 1.51
Differential dynamical effects of macromolecular crowding on an intrinsically disordered protein and a globular protein: implications for in-cell NMR spectroscopy. J Am Chem Soc (2008) 1.49
In-cell NMR spectroscopy. Biochemistry (2001) 1.45
NMR in drug discovery. Nat Rev Drug Discov (2002) 1.40
Integrative database analysis in structural genomics. Nat Struct Biol (2000) 1.14
Technological advances in high-throughput screening. Curr Opin Chem Biol (1998) 1.06
Screening of small molecule interactor library by using in-cell NMR spectroscopy (SMILI-NMR). J Med Chem (2009) 1.05
New assay technologies for high-throughput screening. Curr Opin Chem Biol (1998) 1.03
In-cell NMR for protein-protein interactions (STINT-NMR). Nat Protoc (2006) 1.02
Library design for fragment based screening. Curr Top Med Chem (2005) 1.02
Effects of recombinant protein expression on green fluorescent protein diffusion in Escherichia coli. Biochemistry (2009) 0.98
Integration of NMR and high-throughput screening. Comb Chem High Throughput Screen (2002) 0.98
In-cell biochemistry using NMR spectroscopy. PLoS One (2008) 0.97
Nuclear magnetic resonance-based approaches for lead generation in drug discovery. Methods Enzymol (2001) 0.93
In-Cell NMR spectroscopy: inhibition of autologous protein expression reduces Escherichia coli lysis. Cell Biochem Biophys (2006) 0.91
Structural biology: Inside the living cell. Nature (2009) 0.81
Mapping structural interactions using in-cell NMR spectroscopy (STINT-NMR). Nat Methods (2006) 2.15
Advanced glycation end product recognition by the receptor for AGEs. Structure (2011) 1.84
Structural basis for pattern recognition by the receptor for advanced glycation end products (RAGE). J Biol Chem (2008) 1.51
Semisynthesis of a segmental isotopically labeled protein splicing precursor: NMR evidence for an unusual peptide bond at the N-extein-intein junction. Proc Natl Acad Sci U S A (2004) 1.51
Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches. J Biol Chem (2006) 1.40
Autoregulation of a bacterial sigma factor explored by using segmental isotopic labeling and NMR. Proc Natl Acad Sci U S A (2002) 1.36
Biosynthesis of a fully functional cyclotide inside living bacterial cells. Chembiochem (2007) 1.25
Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. Chembiochem (2009) 1.24
Spartin activates atrophin-1-interacting protein 4 (AIP4) E3 ubiquitin ligase and promotes ubiquitination of adipophilin on lipid droplets. BMC Biol (2010) 1.14
A full-length group 1 bacterial sigma factor adopts a compact structure incompatible with DNA binding. Chem Biol (2008) 1.11
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J Med Chem (2012) 1.10
Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin. Angew Chem Int Ed Engl (2010) 1.07
Screening of small molecule interactor library by using in-cell NMR spectroscopy (SMILI-NMR). J Med Chem (2009) 1.05
Signal transduction in receptor for advanced glycation end products (RAGE): solution structure of C-terminal rage (ctRAGE) and its binding to mDia1. J Biol Chem (2011) 1.04
NMR study of the cataract-linked P23T mutant of human gammaD-crystallin shows minor changes in hydrophobic patches that reflect its retrograde solubility. Biochem Biophys Res Commun (2009) 1.03
Both Ca2+ and Zn2+ are essential for S100A12 protein oligomerization and function. BMC Biochem (2009) 1.03
The receptor for advanced glycation end products (RAGE) specifically recognizes methylglyoxal-derived AGEs. Biochemistry (2014) 1.02
In-cell NMR for protein-protein interactions (STINT-NMR). Nat Protoc (2006) 1.02
In-cell biochemistry using NMR spectroscopy. PLoS One (2008) 0.97
Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions. Angew Chem Int Ed Engl (2013) 0.94
Disulfide bridges remain intact while native insulin converts into amyloid fibrils. PLoS One (2012) 0.94
Segmental isotopic labeling for structural biological applications of NMR. Methods Mol Biol (2004) 0.92
Role of the interdomain linker in distance determination for remote cleavage by homing endonuclease I-TevI. J Mol Biol (2008) 0.90
One RNA aptamer sequence, two structures: a collaborating pair that inhibits AMPA receptors. Nucleic Acids Res (2009) 0.89
In-cell NMR spectroscopy. Prog Nucl Magn Reson Spectrosc (2010) 0.88
Palmitic Acid Is a Novel CD4 Fusion Inhibitor That Blocks HIV Entry and Infection. AIDS Res Hum Retroviruses (2009) 0.87
Recombinant production of rhesus θ-defensin-1 (RTD-1) using a bacterial expression system. Mol Biosyst (2012) 0.85
Biosynthesis and antimicrobial evaluation of backbone-cyclized α-defensins. Biochemistry (2011) 0.84
Structure of proteins in eukaryotic compartments. J Am Chem Soc (2012) 0.84
Fate of pup inside the Mycobacterium proteasome studied by in-cell NMR. PLoS One (2013) 0.83
The role of spartin and its novel ubiquitin binding region in DALIS occurrence. Mol Biol Cell (2014) 0.83
Using singular value decomposition to characterize protein-protein interactions by in-cell NMR spectroscopy. Chembiochem (2014) 0.82
Increased hydrophobicity and decreased backbone flexibility explain the lower solubility of a cataract-linked mutant of γD-crystallin. J Mol Biol (2011) 0.82
Combinatorial library of improved peptide aptamers, CLIPs to inhibit RAGE signal transduction in mammalian cells. PLoS One (2013) 0.81
Structural biology: Inside the living cell. Nature (2009) 0.81
Palmitic acid analogs exhibit nanomolar binding affinity for the HIV-1 CD4 receptor and nanomolar inhibition of gp120-to-CD4 fusion. PLoS One (2010) 0.79
Efficient one-pot cyclization/folding of Rhesus θ-defensin-1 (RTD-1). Bioorg Med Chem Lett (2012) 0.79
Structural determination of biomolecular interfaces by nuclear magnetic resonance of proteins with reduced proton density. J Biomol NMR (2010) 0.78
Inhibition of HIV-1 infection in ex vivo cervical tissue model of human vagina by palmitic acid; implications for a microbicide development. PLoS One (2011) 0.77
Segmental labeling to study multidomain proteins. Adv Exp Med Biol (2012) 0.76
Molecular mechanism of the chaperone function of mini-α-crystallin, a 19-residue peptide of human α-crystallin. Biochemistry (2014) 0.76
Specific RNA-protein interactions detected with saturation transfer difference NMR. RNA Biol (2013) 0.76
Pyrazinamide, but not pyrazinoic acid, is a competitive inhibitor of NADPH binding to Mycobacterium tuberculosis fatty acid synthase I. Bioorg Med Chem Lett (2011) 0.76
Analogs of the antituberculous agent pyrazinamide are competitive inhibitors of NADPH binding to M. tuberculosis fatty acid synthase I. Chem Biodivers (2012) 0.75